HarmJan Bogaard

38PUBLICATIONS
186CO-AUTHORS
Medical devicesRespiratory diseasesMechanobiologyPharmacogenomicsClinical psychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jul 25, 2026
Empagliflozin Ameliorates Experimental Pulmonary Vascular Remodeling, but May Not Benefit Patients With Pulmonary Arterial Hypertension.

|Jun 11, 2026
Identification of Pulmonary Arterial Hypertension Patients with Venous or Capillary Involvement.

|Jan 21, 2026
BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial Hypertension.

Clarissa Becher, Esmee J Groeneveld, Rozenn Quarck

|Feb 22, 2025
Disease-Drug-Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic Analysis.

Medhat M Said, Job R Schippers, Leila Atmowihardjo

|Jan 08, 2025
Pharmacotherapy from Pre-COVID to Post-COVID: Longitudinal Trends and Predictive Indicators for Long COVID Symptoms.

Nadia Baalbaki, Sien T Verbeek, Harm Jan Bogaard

|Oct 22, 2024
Deep phenotyping of pulmonary edema and pulmonary vascular permeability in COVID-19 ARDS.

Job R Schippers, Leila N Atmowihardjo, Erik Duijvelaar

Pageof 7

Frequent Collaborators

10 joint publications

Frances S de Man

7 joint publications

Anton Vonk Noordegraaf

7 joint publications

Jurjan Aman

7 joint publications

Marie-Jose Goumans